Stockscreener 앱 받기
217.14
2.20%
-4.88
시장 영업 전:
217.14
Resmed Inc 주식(RMD)의 최신 뉴스
ResMed Inc. (NYSE:RMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Vanguard Group Inc. Lowers Stock Position in ResMed Inc. $RMD - MarketBeat
M&T Bank Corp Has $3.01 Million Holdings in ResMed Inc. $RMD - MarketBeat
Certuity LLC Increases Stake in ResMed Inc. $RMD - MarketBeat
Should you continue to hold Resmed stock in your portfolio? - MSN
Morgan Stanley cuts ResMed stock price target on market competition - Investing.com
Morgan Stanley cuts ResMed stock price target on market competition By Investing.com - Investing.com Canada
KeyBanc Adjusts Price Target on ResMed to $290 From $302, Maintains Overweight Rating - marketscreener.com
What Makes ASX All Ords ResMed (ASX:RMD) and Xero (ASX:XRO) Stand Out? - Kalkine Media
ResMed Inc. stock (US7611521078): Why Google Discover changes matter more now - AD HOC NEWS
ResMed, Inc. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
ResMed Steps Up PAP Innovation With New Amalfi vs. CLA11 Sleep Apnea Study - TipRanks
Resmed Inc Annual Shareholders Meeting Transcript - GuruFocus
Earnings Preview: ResMed to Report Financial Results Post-market on April 30 - Moomoo
Is It Time To Reassess ResMed (RMD) After Recent Share Price Weakness - Yahoo Finance
Universal Beteiligungs und Servicegesellschaft mbH Buys 6,095 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc stock hits 52-week low at 218.27 USD By Investing.com - Investing.com Australia
ResMed Inc. stock falls Thursday, underperforms market - MarketWatch
ResMed (NYSE:RMD) Reaches New 52-Week LowWhat's Next? - MarketBeat
ResMed Inc stock hits 52-week low at 218.27 USD - Investing.com
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Resmed's Q3 Earnings on Deck: What's in Store for the Stock? - TradingView
ResMed Inc. $RMD Shares Purchased by KLP Kapitalforvaltning AS - MarketBeat
Zurcher Kantonalbank Zurich Cantonalbank Reduces Stock Position in ResMed Inc. $RMD - MarketBeat
RMD Stock Price, Quote & Chart | RESMED INC (NYSE:RMD) - ChartMill
ResMed (RMD) Projected to Post Earnings on Thursday - MarketBeat
Global Respiratory Care Devices Market to Grow at a Substantial Growth Rate of ~8% by 2034 | DelveInsight - GlobeNewswire Inc.
OVERSEA CHINESE BANKING Corp Ltd Sells 7,795 Shares of ResMed Inc. $RMD - MarketBeat
Mirae Asset Global Investments Co. Ltd. Boosts Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc stock (US75102W1036): Is its sleep apnea dominance strong enough for long-term investor g - AD HOC NEWS
ResMed Inc. stock (US7611521078): Is its sleep apnea dominance strong enough for long-term investor - AD HOC NEWS
ResMed Inc. (RMD) stock price, news, quote and history - Yahoo Finance Singapore
Why ResMed (RMD) is Poised to Beat Earnings Estimates Again - Yahoo Finance
ResMed Inc. stock (US7611521078): Is the U.S. sleep apnea market strong enough to unlock new upside? - AD HOC NEWS
ResMed Inc. (RMD) Investor Outlook: Unveiling a 28% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
JPMorgan Issues Overweight Rating for ResMed Amid Sleep Apnea Shift - HarianBasis.co
JPMorgan Initiates ResMed (RMD) With “Overweight” Rating and A$37.6 PT - Insider Monkey
Mizuho Maintains ResMed Inc.Depositary Receipt (RSMDF) Outperform Recommendation - MSN
Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD - MarketBeat
ResMed Inc. stock rises Friday, outperforms market - MarketWatch
Should You Continue to Hold Resmed Stock in Your Portfolio? - TradingView
KBC Group NV Has $57.23 Million Position in ResMed Inc. $RMD - MarketBeat
Hendershot Investments Inc. Increases Holdings in ResMed Inc. $RMD - MarketBeat
INVESCO V.I. Health Care Fund's ResMed Inc(RMD) Holding History - GuruFocus
Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares? - The Motley Fool Australia
ResMed Inc. stock (US7611521078): Why does its sleep apnea dominance matter more now? - AD HOC NEWS
ResMed (NYSE:RMD) Now Covered by JPMorgan Chase & Co. - MarketBeat
Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating - marketscreener.com
ResMed Inc. $RMD Shares Sold by Robeco Institutional Asset Management B.V. - MarketBeat
ResMed Inc. stock (US7611521078): Is sleep apnea market growth strong enough to unlock new upside? - AD HOC NEWS
ResMed Inc. $RMD Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
RMD Analyst Rating Maintained at Outperform by Evercore ISI - Meyka
ResMed Inc (NYSE:RMD): A Durable Dividend Growth Stock for Passive Income - ChartMill
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD) Receives a Buy from Ord Minnett - The Globe and Mail
ResMed Inc. (RMD) Stock Analysis: Exploring a 29.56% Upside Potential with Robust Revenue Growth - DirectorsTalk Interviews
Wells Fargo Analyst Raises ResMed (RMD) Price Target to $270 | R - GuruFocus
ResMed Inc. CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh Trade Ideas — LSX:935168 - TradingView
0.80%
자본화:
|
볼륨(24시간):